The elderly account for the majority of medical spending in many countries, raising concerns about potentially unnecessary spending, especially during the final months of life. Using a well-defined ...

Whether a conservative strategy of medical therapy alone or a strategy of medical therapy plus invasive treatment is more beneficial in older adults with non–ST-segment elevation myocardial infarction ...

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...

Timely recognition of symptoms like chest pain, breathlessness, syncope, palpitations, or sudden neurological deficits can ...

The risk for major adverse cardiovascular events is a recognized, important complication reported among patients with ANCA-associated vasculitis.

STEMI patients without standard modifiable CV risk factors face higher 30-day mortality compared with those with at least 1 risk factor.

Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic or obstructed, resulting in cardiac tissue necrosis. Due to the irreversible ...

Cardiologist evaluation for post-noncardiac surgery PMI patients reduces one-year risks of major adverse cardiac events and all-cause death.

HPV is hypothesized to affect vascular inflammation and atherosclerosis, researchers say ...